New procedure brings chemo to melanoma

March 2, 2018 by Charles Jolie, Rush University Medical Center
Cristina O'Donoghue, MD, MPH. Credit: Rush University Medical Center

The choice between saving one's limb or one's life may seem obvious. However, surgical oncologist Cristina O'Donoghue, MD, MPH, knows the decision is emotionally wrenching for patients with advanced melanoma or sarcoma in a limb that likely would be fatal if allowed to metastasize.

O'Donoghue is one of fewer than 30 surgeons in the country who perform a minimally invasive procedure called isolated infusion (ILI), which delivers high doses of chemotherapy to an affected arm or leg but not the rest of the body.

"Amputation has been the only option for many with advanced melanoma or sarcoma," O'Donoghue says. "But being able to temporarily isolate the flow of blood to and from the limb means very powerful chemotherapy is now an option."

O'Donoghue's first ILI patient at Rush was a limousine driver who would have been unable to work without his right leg and had already failed two previous sarcoma surgeries and radiation.

Chemotherapy drugs travel through the bloodstream killing rapidly growing cells, a feature of cancer cells. But these drugs cannot distinguish cancer cells from rapidly growing healthy cells, like those that make hair and blood or are found in the reproductive system and the digestive tract.

Chemotherapy drugs are usually not as effective against melanomas as they are against other types of cancers, requiring more highly concentrated dosages and causing more severe side effects when delivered in the usual manner throughout the body.

"But by isolating the arm or leg, we can deliver powerful doses to the where the cancer is and spare the rest of the body," she says.

O'Donoghue's first ILI patient at Rush was a limousine driver who would have been unable to work without both legs and already had undergone two previous treatments for sarcoma.

During the procedure, blood circulation to the limb is stopped with a tourniquet, and heated are manually infused into the limb using a series of catheters while the patient is under a general anesthetic. After 30 minutes, the limb is flushed clear of the chemo with a saline solution, the tourniquet is removed and circulation is restored.

ILI is actually a more advanced version of isolated limb perfusion, a regionalized chemotherapy technique developed in the 1950s that involves the more invasive process of bypassing the flow of blood to the limb via a major artery. Performing the chemo infusion via catheters closer to the tumor, instead of perfusion directly into a major artery, means ILI can be performed again should the cancer reappear.

"Isolated limb perfusion remains a very viable option for many patients, but the minimally invasive nature of ILI can provide even more life- and limb-saving options. Major surgery should always be a last option," O'Donoghue says.

ILI is an important addition to Rush's armamentarium of treatments for melanoma and sarcoma, two aggressive types of soft tissue cancer. Rush is one of the top centers in Illinois for the treatment of sarcoma, and with the addition of ILI, Rush is a leader in melanoma treatment in Chicago as well. Rush is the only health system in Chicago to offer ILI.

In 2014, an estimated 1.2 million Americans were living with melanoma, the deadliest skin cancer, O'Donoghue says. Melanoma is the third most common cancer among women ages 20 to 39 and the second most common cancer in men ages 20 to 39.

Both and melanoma are often fatal because they spread aggressively, but are curable when caught early. According to the American Cancer Society, melanoma accounts for fewer than five percent of all skin cancer cases but is the leading cause of death from . In addition, the number of new cases of melanoma has been rising steadily.

ILI shortens hospital stay, saves limbs and extends lives

O'Donoghue is lead author the largest assessment ever of ILI at a single center in the United States. "Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions," published October, 2017 in the journal Annals of Surgical Oncology shows that ILI saves limbs, extends lives and is well tolerated by most people

Of 163 patients who underwent ILI from 2007 to 2016, the median hospital stay was only five days, and 88 percent had no worse effects than redness and swelling in the treated limb. On average, melanoma patients who responded to the ILI procedure lived 56 months longer than non-responders. ILI has demonstrated response rates of between 54 and 84% for .

Besides ILI, other treatments for soft tissue cancers including non-metastasized melanomas and sarcomas at Rush include injections of T-Vec—a genetically modified cancer-killing virus—immunotherapies and other surgical techniques.

Explore further: Regional chemotherapy technique for extremity sarcoma salvages limbs from amputation

More information: Cristina O'Donoghue et al. Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions, Annals of Surgical Oncology (2017). DOI: 10.1245/s10434-017-6107-9

Related Stories

Regional chemotherapy technique for extremity sarcoma salvages limbs from amputation

February 15, 2017
Patients with a type of advanced malignant cancer of the arms or legs have typically faced amputation of the afflicted limb as the only treatment option. However, a technique that limits the application of chemotherapy to ...

Viral therapy could boost limb-saving cancer treatment

July 22, 2014
Viruses designed to target and kill cancer cells could boost the effectiveness of chemotherapy to the arms and legs and help avoid amputation, a new study reports.

Rare melanoma type highly responsive to immunotherapy

January 11, 2018
Desmoplastic melanoma is a rare subtype of melanoma that is commonly found on sun-exposed areas, such as the head and neck, and usually seen in older patients. Treatment is difficult because these tumors are often resistant ...

Role of melanoma-promoting protein revealed

December 6, 2017
In a new study, Yale researchers describe the role of a protein that promotes growth of melanoma, the deadliest form of skin cancer.

Surgery may be best for advanced melanoma

April 5, 2017
(HealthDay)—Surgery to remove melanoma—the deadliest form of skin cancer—can extend the lives of patients whose disease has spread to the abdomen area, new research suggests.

Recommended for you

Cancer comes back all jacked up on stem cells

March 19, 2018
After a biopsy or surgery, doctors often get a molecular snapshot of a patient's tumor. This snapshot is important - knowing the genetics that cause a cancer can help match a patient with a genetically-targeted treatment. ...

A small, daily dose of Viagra may reduce colorectal cancer risk

March 19, 2018
A small, daily dose of Viagra significantly reduces colorectal cancer risk in an animal model that is genetically predetermined to have the third leading cause of cancer death, scientists report.

Researchers create a drug to extend the lives of men with prostate cancer

March 16, 2018
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.